0001209191-17-013001.txt : 20170221 0001209191-17-013001.hdr.sgml : 20170221 20170221210045 ACCESSION NUMBER: 0001209191-17-013001 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170217 FILED AS OF DATE: 20170221 DATE AS OF CHANGE: 20170221 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CENTRAL GARDEN & PET CO CENTRAL INDEX KEY: 0000887733 STANDARD INDUSTRIAL CLASSIFICATION: WHOLESALE-MISCELLANEOUS NONDURABLE GOODS [5190] IRS NUMBER: 680275553 STATE OF INCORPORATION: DE FISCAL YEAR END: 0926 BUSINESS ADDRESS: STREET 1: 1340 TREAT BOULEVARD STREET 2: SUITE 600 CITY: WALNUT CREEK STATE: CA ZIP: 94597 BUSINESS PHONE: 9259484000 MAIL ADDRESS: STREET 1: 1340 TREAT BOULEVARD STREET 2: SUITE 600 CITY: WALNUT CREEK STATE: CA ZIP: 94597 FORMER COMPANY: FORMER CONFORMED NAME: CENTRAL GARDEN & PET COMPANY DATE OF NAME CHANGE: 19941019 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BALOUSEK JOHN CENTRAL INDEX KEY: 0001168586 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33268 FILM NUMBER: 17626890 MAIL ADDRESS: STREET 1: 303 PEACHTREE CENTER AVE STREET 2: SUITE 500 CITY: ALTANTA STATE: GA ZIP: 30303 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-02-17 0 0000887733 CENTRAL GARDEN & PET CO CENT 0001168586 BALOUSEK JOHN C/O CENTRAL GARDEN & PET COMPANY 1340 TREAT BLVD, SUITE 600 WALNUT CREEK CA 94597 1 0 0 0 Common Stock 2017-02-17 4 S 0 12000 35.5024 D 18160 I By Limited Partnership Class A Common Stock 630 D Class A Common Stock 1455 I By Limited Partnership Shares sold through sales plan pursuant to Rule 10b5-1(c)(1) of the Securities Exchange Act of 1934, as amended. The range of prices for the shares of Common Stock is from $35.28 to $35.6450. Mr. Balousek undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities sold at each separate price. By Balousek Family L.P. Mr. Balousek is the general partner of Balousek Family L.P. Mr. Balousek disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. /s/ JoAnn Jonte, as Attorney-in-Fact for John Balousek 2017-02-21